Therapeutic Area | MeSH |
---|---|
mental disorders | D001523 |
Brand Name | Status | Last Update |
---|---|---|
milnacipran hcl | ANDA | 2024-07-30 |
savella | New Drug Application | 2025-03-04 |
savella savella | New Drug Application | 2017-12-31 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
major depressive disorder | EFO_0003761 | D003865 | F22 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Milnacipran Hydrochloride, Savella, Abbvie | |||
7994220 | 2029-09-19 | U-819 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 1 | 5 | 10 | 8 | 5 | 28 |
Myofascial pain syndromes | D009209 | EFO_1001054 | — | 1 | 4 | 10 | 8 | 5 | 27 |
Depression | D003863 | — | F33.9 | — | 4 | 10 | 3 | 6 | 22 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | — | 4 | 10 | 3 | 1 | 17 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | — | 2 | 8 | 3 | 1 | 14 |
Syndrome | D013577 | — | — | — | 1 | 2 | 1 | 1 | 5 |
Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | 3 | — | 3 |
Chronic pain | D059350 | — | — | — | — | — | 2 | 1 | 3 |
Fatigue | D005221 | — | R53.83 | — | 1 | — | 1 | — | 2 |
Migraine disorders | D008881 | EFO_0003821 | G43 | — | — | — | 1 | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Back pain | D001416 | — | M54 | — | 1 | 1 | — | — | 2 |
Vulvodynia | D056650 | — | N94.81 | — | — | 1 | — | — | 1 |
Vulvar vestibulitis | D054515 | — | N94.810 | — | — | 1 | — | — | 1 |
Peripheral nervous system diseases | D010523 | — | G64 | — | — | 1 | — | — | 1 |
Disease progression | D018450 | — | — | — | 1 | 1 | — | — | 1 |
Cognitive neuroscience | D000066494 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuralgia | D009437 | EFO_0009430 | — | — | 1 | — | — | — | 1 |
Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | 1 | — | — | — | 1 |
Low back pain | D017116 | — | M54.5 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hyperalgesia | D006930 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 1 | 1 |
Tobacco use disorder | D014029 | — | F17 | — | — | — | — | 1 | 1 |
Post-lyme disease syndrome | D000077342 | — | — | — | — | — | — | 1 | 1 |
Ischemic stroke | D000083242 | — | — | — | — | — | — | 1 | 1 |
Postpartum period | D049590 | — | — | — | — | — | — | 1 | 1 |
Labor pain | D048949 | — | — | — | — | — | — | 1 | 1 |
Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | — | — | — | 1 | 1 |
Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | — | 1 | 1 |
Birth order | D001722 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Milnacipran |
INN | milnacipran |
Description | (1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-1-cyclopropanecarboxamide is a member of acetamides. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CCN(CC)C(=O)C1(c2ccccc2)CC1CN |
PDB | — |
CAS-ID | 92623-85-3 |
RxCUI | — |
ChEMBL ID | CHEMBL259209 |
ChEBI ID | — |
PubChem CID | 65833 |
DrugBank | DB04896 |
UNII ID | G56VK1HF36 (ChemIDplus, GSRS) |